[HTML][HTML] Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention
JP Hussman - Frontiers in pharmacology, 2020 - frontiersin.org
With the objective of linking early findings relating to the novel SARS-CoV-2 coronavirus
with potentially informative findings from prior research literature and to promote …
with potentially informative findings from prior research literature and to promote …
[HTML][HTML] Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control
COVID-19 has caused numerous deaths as well as imposed social isolation and upheaval
world-wide. Although, the genome and the composition of the virus, the entry process and …
world-wide. Although, the genome and the composition of the virus, the entry process and …
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …
[HTML][HTML] The role of post-transcriptional regulation in SARS-CoV-2 infection and pathogenicity
X Wang, Z Chang, T Zhao, W Zhong, J Shi… - Frontiers in …, 2023 - frontiersin.org
The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) virus has had a significant impact on global social and economic stability. To …
(SARS-CoV-2) virus has had a significant impact on global social and economic stability. To …
Molecular basis of pathogenesis of coronaviruses: a comparative genomics approach to planetary health to prevent zoonotic outbreaks in the 21st century
In the first quarter of the 21st century, we are already facing the third emergence of a
coronavirus outbreak, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
coronavirus outbreak, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
N Hartog, W Faber, A Frisch, J Bauss… - Expert review of …, 2021 - Taylor & Francis
Introduction: The year 2020 was defined by the 29,903 base pairs of RNA that codes for the
SARS-CoV-2 genome. SARS-CoV-2 infects humans to cause COVID-19, spreading from …
SARS-CoV-2 genome. SARS-CoV-2 infects humans to cause COVID-19, spreading from …
Pathogenesis of COVID-19, disease outbreak: a review
Coronavirus-19 is a severe acute respiratory disorder in humans which has become a major
health problem. It spreads out very rapidly throughout the world since it has been first …
health problem. It spreads out very rapidly throughout the world since it has been first …
Immunopathology and Immunopathogenesis of COVID-19, what we know and what we should learn
Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts
with host's epithelial and immune cells, leading to inflammatory response induction, which is …
with host's epithelial and immune cells, leading to inflammatory response induction, which is …
[HTML][HTML] Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
H Latifi-Pupovci - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the outbreak of
unusual viral pneumonia that emerged in late 2019 in the city of Wuhan, China. Since then …
unusual viral pneumonia that emerged in late 2019 in the city of Wuhan, China. Since then …
[PDF][PDF] The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.
C Li, BH Xu - European Review for Medical & Pharmacological …, 2020 - europeanreview.org
Coronavirus Disease-2019 (COVID-19) caused by SARS-CoV-2 infection has rapidly
spread all over the world, in just two months. As of 27 March, globally, 509,164 cases …
spread all over the world, in just two months. As of 27 March, globally, 509,164 cases …